Evolent Health (EVH) Receives a Rating Update from a Top Analyst

By Ryan Adsit

Cantor Fitzgerald analyst Steven Halper reiterated a Buy rating on Evolent Health (EVHResearch Report) today and set a price target of $37. The company’s shares closed on Friday at $19.71.

Halper said:

“We reaffirm our Overweight rating and $37 PT on EVH. EVH’s population health-management tools enable healthcare organizations to transition to value-based reimbursement. Its primary customers include captive health insurance plans of large, integrated delivery networks. Given the ongoing shift to value-based reimbursement, we believe EVH is well-positioned to grow rapidly given the large addressable market. Despite some concerns about the future of the Affordable Care Act (ACA), we believe market forces will continue to drive the shift to value-based reimbursement in many large population markets.”

According to TipRanks.com, Halper is a top 100 analyst with an average return of 15.9% and a 59.4% success rate. Halper covers the Services sector, focusing on stocks such as WellCare Health Plans, Tivity Health Inc, and Hms Holdings Corp.

Evolent Health has an analyst consensus of Strong Buy, with a price target consensus of $33.38, implying a 69.4% upside from current levels. In a report issued on December 21, Oppenheimer also assigned a Buy rating to the stock with a $31 price target.


See today’s analyst top recommended stocks >>

Based on Evolent Health’s latest earnings release for the quarter ending September 30, the company reported a quarterly GAAP net loss of $12.43 million. In comparison, last year the company had a GAAP net loss of $13.16 million.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Evolent Health, Inc. engages in the provision of health care delivery and payment services. Its solutions include population health management, health plan administration and third party administration, network performance management, risk adjustment, pharmacy benefit management, analytics and performance improvement, and technology and electronic medical record integration. The company was founded by Frank J. Williams, Seth B. Blackley, and Tom Peterson in August 2011 and is headquartered in Arlington, VA.